Rheumatic heart disease. Mediation by complex immune events

Advances in Clinical Chemistry

Volumn 53, Issue C, 2011, Pages 31-50

  Guilherme, L ^a   Kohler K F ^a   Kalil, J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650978285     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385855-9.00002-3     Document Type: Book

References (65)

1. Mota C.C., Aiello D.V., Anderson R.H. Chronic rheumatic heart disease. Pediatric Cardiology 2009, 1091-1133. Churchill Livingstone/Elsevier, Philadelphia. 3rd edition. R.H. Anderson, E.J. Baker, D.J. Penny (Eds.).
2. Guilherme L., Cury P., Demarchi L.M., et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am. J. Pathol. 2004, 165:1583-1591.
3. Carapetis J.R., Steer A.C., Mulholland E.K., Weber M. The global burden of group A streptococcal disease. Lancet. Infect. Dis. 2005, 5:685-694.
4. Barbosa P.J.B., Muller R.E., Al Latado, et al. Brazilian guidelines for diagnostic, treatment and prevention of rheumatic fever. Arq. Bras. Cardiol. 2009, 93:1-18.
5. Ayoub E.M., Barrett D.J., Maclaren N.K., Krischer J.P. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J. Clin. Invest. 1986, 77:2019-2026.
6. Maharaj B., Hammond M.G., Appadoo B., Leary W.P., Pudifin D.J. HLA-A, B, DR and DQ antigens in black patients with severe chronic rheumatic heart disease. Circulation 1987, 76:259-261.
7. Monplaisir N., Valette I., Bach J.F. HLA antigens in 88 cases of rheumatic fever observed in Martinique. Tissue Antigens 1986, 28:209-213.
8. Donadi E.A., Smith A.G., Louzada-Júnior P., Voltarelli J.C., Nepom G.T. HLA class I and class II profiles of patients presenting with Sydenham's chorea. J. Neurol. 2000, 247:122-128.
9. Hernandez-Pacheco G., Aguilar-Garcia J., Flores-Dominguez C., et al. MHC class II alleles in Mexican patients with rheumatic heart disease. Int. J. Cardiol. 2003, 92:49-54.
10. Jhinghan B., Mehra N.K., Reddy K.S., Taneja V., Vaidya M.C., Bhatia M.L. HLA, blood groups and secretor status in patients with established rheumatic fever and rheumatic heart disease. Tissue Antigens 1986, 27:172-178.
11. Ozkan M., Carin M., Sonmez G., Senocak M., Ozdemir M., Yakut C. HLA antigens in Turkish race with rheumatic heart disease. Circulation 1993, 87:1974-1978.
12. Anastasiou-Nana M.I., Anderson J.L., Carlquist J.F., Nanas J.N. HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors. Am. Heart. J. 1986, 112:992-997.
13. Rajapakse C.N., Halim K., Al-Orainey I., Al-Nozha M., Al-Aska A.K. A genetic marker for rheumatic heart disease. Br. Heart. J. 1987, 58:659-662.
14. Olmez U., Turgay M., Ozenirler S., et al. Association of HLA class I and class II antigens with rheumatic fever in a Turkish population. Scand. J. Rheumatol. 1993, 22:49-52.
15. Guedez Y., Kotby A., El-Demellawy M., et al. HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation 1999, 99:2784-2790.
16. Guilherme L., Weidebach W., Kiss M.H., Snitcowsky R., Kalil J. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 1991, 83:1995-1998.
17. Visentainer J.E., Pereira F.C., Dalalio M.M., Tsuneto L.T., Donadio P.R., Moliterno R.A. Association of HLA-DR7 with rheumatic fever in the Brazilian population. J. Rheumatol. 2000, 27:1518-1520.
18. Haydardedeoglu F.E., Tutkak H., Kose K., Duzgun N. Genetic susceptibility to rheumatic heart disease and Streptococcal pharyngitis: association with HLA-DR alleles. Tissue Antigens 2006, 68:293-296.
19. Stanevicha V., Eglite J., Sochnevs A., Gardovska D., Zavadska D., Shantere R. HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia. Arthritis. Res. Ther. 2003, 5:340-346.
20. Koyanagi T., Koga Y., Nishi H., et al. DNA typing of HLA class II genes in Japanese patients with rheumatic heart disease. J. Mol. Cell. Cardiol. 1996, 28:1349-1353.
21. Hernández-Pacheco G., Flores-Domínguez C., Rodríguez-Pérez J.M., et al. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. Autoimmunity 2003, 21:59-63.
22. Ramasawmy R., Faé K.C., Spina G., et al. Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever. Mol. Immunol. 2007, 44:1873-1878.
23. Sallakci N., Akcurin G., Köksoy S., et al. TNF-alpha G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF-alpha production. J. Autoimmun. 2005, 25:150-154.
24. Settin A., Abdel-Hady H., El-Baz R., Saber I. Gene polymorphisms of TNF-alpha(-308), IL-10(-1082), IL-6(-174) and IL-1Ra (VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatr. Cardiol. 2007, 28:363-371.
25. Miller L.C., Gray E.D., Mansour M., et al. Cytokines and immunoglobulin in rheumatic heart disease: production by blood and tonsillar mononuclear cells. J. Rheumatol. 1989, 16:1436-1442.
26. Morris K., Mohan C., Wahi P.L., Anand I.S., Ganguly N.K. Enhancement of IL-1, IL-2 production and IL-2 receptor generation in patients with acute rheumatic fever and active rheumatic heart disease; a prospective study. Clin. Exp. Immunol. 1993, 91:429-436.
27. Narin N., Kutukculer N., Ozyurek R., Bakiler A.R., Parlar A., Arcasoy M. Lymphocyte subsets and plasma IL-1 alpha, IL-2 and TNF-alpha concentrations in acute rheumatic fever and chronic rheumatic heart disease. Clin. Immunol. Immunopathol. 1995, 77:172-176.
28. Yegin O., Coskun M., Ertug H. Cytokines in acute rheumatic fever. Eur. J. Pediatr. 1997, 156:25-29.
29. Kamal H., Hussein G., Hassoba H., Mosaad N., Gad A., Ismail M. Transforming growth factor-beta1 gene C-509T and T869C polymorphisms as possible risk factors in rheumatic heart disease in Egypt. Acta. Cardiol. 2010, 65:177-183.
30. Chou H.T., Chen C.H., Tsai C.H., Tsai F.J. Association between transforming growth factor-beta1 gene C-509T and T869C polymorphisms and rheumatic heart disease. Am. Heart. J. 2004, 148:181-186.
31. Azevedo P.M., Bauer R., Caparbo V.F., Silva C.A., Bonfá E., Pereira R.M. Interleukin-1 receptor antagonist gene (IL1RN) polymorphism possibly associated to severity of rheumatic carditis in a Brazilian cohort. Cytokine 2010, 49:109-113.
32. Schafranski M.D., Ferrari P.L., Scherner D., Torres R., Jensenius J.C., Messias-Reason I.J.de High-producing MBL2 genotypes increase the risk of acute and chronic carditis in patients with history of rheumatic fever. Mol. Immunol. 2008, 45:3827-3831.
33. Ramasawmy R., Spina G.S., Fae K.C., et al. Association of mannose-binding lectin gene polymorphism but not of mannose-binding serine protease 2 with chronic severe aortic regurgitation of rheumatic etiology. Clin. Vaccine. Immunol. 2008, 15:932-936.
34. Berdeli A., Celik H.A., Ozyürek R., Dogrusoz B., Aydin H.H. TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. J. Mol. Med. 2005, 83:535-541.
35. Runza V.L., Schwaeble W., Männel D.N. Ficolins: novel pattern recognition molecules of the innate immune response. Immunobiology 2008, 213:297-306.
36. Messias-Reason I.J.de, Schafranski M.D., Kremsner P.G., Kun J.F. Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease. Clin. Exp. Immunol. 2009, 157:395-399.
37. Berdeli A., Celik H.A., Ozyürek R., Aydin H.H. Involvement of immunoglobulin FcgammaRIIA and FcgammaRIIIB gene polymorphisms in susceptibility to rheumatic fever. Clin. Biochem. 2004, 37:925-929.
38. Damian R.T. Molecular mimicry: antigen sharing by parasite and host and its consequences. Am. Nat. 1964, 98:129-149.
39. Peterson L.K., Fujinami R.S. Molecular mimicry. Autoantibodies 2007, 13-19. Elsevier, Burlington. 2nd edition. Y. Shoenfeld, M.E. Gershwin, P.L. Meroni (Eds.).
40. Fischetti V.A., Jones K.F., Scott J.R. Size variation of the M protein in group A streptococci. J. Exp. Med. 1985, 161:1384-1401.
41. Cunningham M.W. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 2000, 13:470-511.
42. Guilherme L., Faé K., Oshiro S.E., Kalil J. Molecular pathogenesis of rheumatic fever and rheumatic heart disease. Exp. Rev. Mol. Immunol. 2005, 7:1-15.
43. Cunningham M.W., McCormack J.M., Fenderson P.G., Ho M.K., Beachey E.H., Dale J.B. Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J. Immunol. 1989, 143:2677-2683.
44. Luo Y.H., Chuang W.J., Wu J.J., et al. Molecular mimicry between streptococcal pyrogenic exotoxin B and endothelial cells. Lab. Invest. 2010, 90(10):1492-1506.
45. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256:495-497.
46. Sercarz E.E., Lehmann P.V., Ametani A., Benichou G., Miller A., Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 1993, 11:729-766.
47. Lehmann P.V., Forsthuber T., Miller A., Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992, 359:155-157.
48. Fujinami R.S., Oldstone M.B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985, 230:1043-1045.
49. Wucherpfenning K.W., Strominger J.L. Molecular mimicry in the T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 1995, 80:695-705.
50. Mason D. A very high level of crossreactivity is a essential feature of the T-cell receptor. Immunol. Today 1998, 19:395-404.
51. Mason D. Antigen cross-reactivity: essential in the function of TCRs. The Immunologist 1998, 6:220-222.
52. El-Demellawy M., El-Ridi R., Guirguis N.I., Alim M.A., Kotby A., Kotb M. Preferential recognition of myocardial antigens by T lymphocytes from rheumatic heart disease patients. Infect. Immun. 1997, 65:2197-2205.
53. Guilherme L., Oshiro S.E., Fae K.C., et al. T cell reactivty against streptococcal antigens in the periphery mirrors reactivity of heart infiltrating T lymphocytes in rheumatic heart disease patients. Infect. Immun. 2001, 69:5345-5535.
54. Faé K.C., Kalil J., Toubert A., Guilherme L. Heart infiltrating T cell clones from a rheumatic heart disease patient display a common TCR usage and a degenerate antigen recognition pattern. Mol. Immunol. 2004, 40:1129-1135.
55. Guilherme L., Dulphy N., Douay C., et al. Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients. Int. Immunol. 2000, 12:1063-1074.
56. Guilherme L., Cunha-Neto E., Coelho V., et al. Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognized both streptococcal and cardiac proteins. Circulation 1995, 92:415-420.
57. Fae K.C., Silva D.D., Oshiro S.E., et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J. Immunol. 2006, 176:5662-5670.
58. Manjula B.N., Acharya A.S., Mische M.S., Fairwell T., Fischetti V.A. The complete amino acid sequence of a biologically active 197-residue fragment of M protein isolated from type 5 group A streptococci. J. Biol. Chem. 1984, 259:3686-3693.
59. Miller L.C., Gray E.D., Beachey E.H., Kehoe M.A. Antigenic variation among group A streptococcal M proteins: nucleotide sequence of the serotype 5 M protein gene and its relationship with genes encoding types 6 and 24 M proteins. J. Biol. Chem. 1988, 263:5668-5673.
60. Ellis N.M., Li Y., Hildebrand W., Fischetti V.A., Cunningham M.W. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J. Immunol. 2005, 175:5448-5456.
61. Galvin J.E., Hemric M.E., Ward K., Cunningham M. Cytotoxic monoclonal antibody from rheumatic carditis reacts with human endothelium: implications in rheumatic heart disease. J. Clin. Invest. 2000, 106:217-224.
62. Roberts S., Kosanke S., Dunn T.S., et al. Pathogenic mechanism in rheumatic carditis: focus on valvular endothelium. J. Infect. Dis. 2001, 183:507-511.
63. Raizada V., Williams RCJr, Chopra P., et al. Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-T cells antibodies. Am. J. Med. 1983, 74:225-237.
64. Kemeny E., Grieve T., Marcus R., et al. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin. Immunol. Immunopathol. 1989, 52:225-237.
65. Faé K.C., Diefenbach da Silva D., Bilate A.M., et al. PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients. J. Autoimmun. 2008, 31:136-141.